Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SNRNP48 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ZNF605 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
REXO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BTF3L4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAH9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGKC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
APOC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EMC10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100506088 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SYN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A47 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBR4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00905 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PARVG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VCY1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LY6G6F - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GTSF1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIO - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BAHCC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on